Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- LYKALABS.NSE
- Price
- 77.69
- Stock movement down
- -0.63 (-0.80%)
- Company name
- Lyka Labs Limited
- Exchange
- (NSE ,
- Currency
- INR )
- Sector
- Healthcare >Biotechnology
- Market cap
- 2.77B
- Ent value
- 3.43B
- Price/Sales
- 2.01
- Price/Book
- 2.74
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 134.93
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -53.24%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-12-12
DIVIDENDS
LYKALABS.NSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 134.93 |
| Price to OCF | 17.79 |
| Price to FCF | - |
| Price to EBITDA | 16.66 |
| EV to EBITDA | 20.59 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.01 |
| Price to Book | 2.74 |
| EV to Sales | 2.49 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 35.69M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 11.64M |
| Net receivables | 370.64M |
| Total current assets | 606.16M |
| Goodwill | 0.00 |
| Intangible assets | 80.66M |
| Property, plant and equipment | 792.13M |
| Total assets | 1.68B |
| Accounts payable | 169.40M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 429.80M |
| Total liabilities | 666.70M |
| Shareholder's equity | 1.01B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 80.00 |
| Daily high | 80.00 |
| Daily low | 77.10 |
| Daily Volume | 9K |
| All-time high | 254.30 |
| 1y analyst estimate | - |
| Beta | 0.49 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 2 Feb 2026 |
Downside potential
Loading...
Downside potential data
| LYKALABS.NSE | S&P500 | |
| Current price drop from All-time high | -69.45% | -1.08% |
| Highest price drop | -70.80% | -19.00% |
| Date of highest drop | 8 Dec 2025 | 8 Apr 2025 |
| Avg drop from high | -53.64% | -2.64% |
| Avg time to new high | - | 6 days |
| Max time to new high | 298 days | 89 days |
COMPANY DETAILS
Marketcap
2.77B
Marketcap category
Mid-cap
Description
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant tablets and combination, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, anti-fungal and bacterial, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.
Employees
499
Website
Investor relations
-
SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found